Novartis gets slapped by ethics overseer for dissing Bayer's Eylea; CRO WuXi plans $3.3B management buyout;

@FiercePharma: China FDA issues software guidelines on medical devices effective this month. FiercePharmaAsia story | Follow @FiercePharma

@EricPFierce: Sun U.S. sales gut-kicked by supply constraints as it works on FDA concerns at Halol plant. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Biogen touts new Eloctate data as next-gen hemophilia rivals near the scene. FiercePharmaMarketing article | Follow @CarlyHFierce

> England's code of conduct regulator has ruled in favor of Bayer in a fight with Novartis ($NVS) over claims the Swiss drugmaker made at a conference concerning the two companies' rival eye drugs, Eylea and Aventis. Report

> Chinese CRO WuXi PharmaTech ($WX) has agreed to a $3.3 billion management buyout. Release | More

> Abbott Laboratories ($ABT) has sold to a development group a four-story office building in the Dallas area that it recently vacated. Report

> Pfizer ($PFE) has won another regulator's approval for its $15 billion buyout of Hospira ($HSP), this one from Canada. Release

Medical Device News

@FierceMedDev: Roche shells out up to $425M for superbug testing outfit. FierceDiagnostics news | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Google joins forces with Dexcom for miniaturized glucose monitor. Article | Follow @VarunSaxena2

@EmilyWFierce: NICE plots takeover of England's Cancer Drugs Fund. FiercePharma article | Follow @EmilyWFierce

> NOWDiagnostics gets FDA blessing for one-step pregnancy test. News

> Roche deploying smartphone app to monitor patients during clinical trial of its Parkinson's med. Report

> NIH study sees little benefit to added fetal ECG monitoring during birth. Story

Biotech News

@FierceBiotech: FierceBiotech Radio on Amarin's First Amendment crusade, Martin Shkreli's Twitter, and Kim Kardashian's Instagram. Listen/Subscribe | Follow @FierceBiotech

@JohnCFierce: California cutbacks: Boston Sci to close two facilities, Abbott cuts 160+ employees. FierceMedicalDevices article | Follow @JohnCFierce

@DamianFierce: ICYMI: A wonderfully stern FDA official parses Kim Kardashian's Instagram. Letter | Follow @DamianFierce

> KemPharm spikes as its anti-abuse pain drug rolls toward the FDA. Story

> Lilly's CEO keeps faith in the pipeline as biotech gets 'too expensive.' Article

> CRO giant WuXi is going private in a $3.3B deal. News

> Avalanche hits the brakes on its gene therapy program after a Phase II misstep. Report

And Finally... Scientists have invented a quick method to make potent opioid painkillers using bioengineered baker's yeast instead of poppies, but they need to fine-tune the process to make it commercially viable, a new study says. More

Suggested Articles

Move over, Roche. There’s a new small-cell lung cancer therapy on the scene, and it belongs to AstraZeneca.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Gilead CEO promised to make remdesivir affordable, shortly after the company backed off its request for orphan status amid a public backlash.